US › Healthcare

Nexgel Inc (NXGL)

US · Healthcare · Medical Instruments & Supplies

$0.26+4.35%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$3.7M

Revenue YoY

+27.8%

Net profit

$-3.6M

EPS

$-0.40

EPS estimate

$-0.12

Net margin

-98.6%

EPS came in at -0.40 against a street estimate of -0.12 — a miss of 233.3%.

Key statistics

Market cap

$2.8M

Forward P/E

1.4

P/B

0.57

Book value

$0.51

EPS (TTM)

$-0.74

52-week high

$2.89

52-week low

$0.27

50-day MA

$0.41

200-day MA

$0.88

Beta

0.75

Analyst view

Analysts rate Nexgel Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

14.02%

Institutions

13.67%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.32%
Morgan Stanley - Brokerage Accounts	0.56%
Renaissance Technologies Corp	0.52%
Vanguard Capital Management, LLC	0.50%
Jane Street Group LLC	0.43%
Vanguard Fiduciary Trust Co	0.35%
FLAX POND CAPITAL, LLC	0.21%
XTX Topco Ltd	0.18%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nexgel Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.